Insider Trading July 15, 2026 08:04 PM

Qualys CEO Executes $513k Stock Sale Under Pre-Arranged Plan

Executive transaction follows analyst upgrades and FedRAMP High Authorization for TotalCloud solution

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
QLYS

Qualys, Inc. (NASDAQ:QLYS) CEO and President Sumedh S. Thakar executed a sale of 3,200 shares on July 14, 2026, generating approximately $513,610. The transaction was conducted under a Rule 10b5-1 trading plan established in February 2026. Following the sale, Thakar retains direct ownership of 193,486 shares. The executive move coincides with a period of significant analyst activity and strategic product milestones for the cybersecurity firm.

Qualys CEO Executes $513k Stock Sale Under Pre-Arranged Plan
QLYS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Sumedh S. Thakar sold 3,200 shares worth approximately $513,610 under a Rule 10b5-1 plan, retaining 193,486 shares.
  • Analysts TD Cowen and JPMorgan raised price targets, citing growth in the vulnerability management sector and lower operating expenses, while Scotiabank lowered its target.
  • Qualys achieved FedRAMP High Authorization for its TotalCloud solution, extending compliance standards to the Cloud-Native Application Protection Platform for sensitive government data.

Sumedh S. Thakar, serving as both CEO and President of QUALYS, INC. (NASDAQ:QLYS), divested a portion of his equity stake in the company on July 14, 2026. The transaction involved the sale of 3,200 shares of Qualys common stock. Based on the recorded share prices ranging from $149.30 to $163.565, the total value of the transaction amounted to approximately $513,610.

These sales were executed in accordance with a Rule 10b5-1 trading plan that Thakar adopted on February 27, 2026. This pre-arranged framework typically allows executives to trade stock during periods when they might otherwise be subject to insider trading restrictions. Following the completion of these transactions, Mr. Thakar continues to directly hold 193,486 shares of Qualys common stock.

The executive activity occurs alongside a wave of analyst commentary and strategic developments within the cybersecurity sector. TD Cowen recently raised its price target for Qualys to $145 from $90, while maintaining a Hold rating. The firm projected a 9% year-over-year increase in second-quarter 2026 billings and anticipates a 14% rise in adjusted earnings per share, attributing this growth to lower operating expenses. Similarly, JPMorgan upgraded Qualys from Underweight to Neutral, citing growth in the vulnerability management sector, and raised its price target to $139 from $87.

Conversely, Scotiabank lowered its price target to $100 from $135, maintaining a Sector Perform rating. The institution noted an 8% growth in current billings for the first quarter. On the product front, Qualys announced that its TotalCloud solution achieved FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency. This authorization extends the FedRAMP High status of the Qualys Government Platform to include the Cloud-Native Application Protection Platform, aligning with stringent compliance standards for handling sensitive government data.

Market data indicates the stock closed at $159.32, down $4.80 or 2.92%. In after-hours trading, the stock traded at $158.00, down $1.32 or 0.83%. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment. Investors can access 15 additional ProTips and comprehensive analysis through the platform’s Pro Research Report, available for QLYS and 1,400+ other US equities.

The recent developments reflect a mix of analyst opinions and strategic advancements for Qualys. The company is included in AI-picked strategies, with tools available to review strategies and analyze QLYS. Vision AI features are highlighted to help investors determine where to set stop-losses, deliver complete risk management plans, and validate trades in under 60 seconds. A July sale offering 60% off InvestingPro is currently promoted.

Risks

  • Mixed analyst sentiment presents uncertainty, with Scotiabank lowering its price target to $100 from $135, contrasting with upgrades from TD Cowen and JPMorgan.
  • The executive stock sale, while conducted under a pre-arranged plan, may signal internal valuation perspectives to the market, impacting investor confidence in the cybersecurity sector.

More from Insider Trading

Mineralys Therapeutics CMO Rodman Executes Pre-Arranged Share Sales Under Rule 10b5-1 Plan Jul 15, 2026 Mineralys Therapeutics CEO Jon Congleton Sells $291,441 in Stock Jul 15, 2026 CrowdStrike CEO George Kurtz Executes $3.92 Million Stock Sale Under Pre-Arranged Plan Jul 15, 2026 CrowdStrike Director Denis O'Leary Offloads $2.72M in Shares Jul 15, 2026 CoreWeave Executive McBee Brannin Liquidates $4.49M in Shares Amid Stock Volatility Jul 15, 2026